The antiproliferative activity of 6-substituted polycarbonitrile derivatives of 3-azabicyclo[3.1.0]hexane was studied. It was established that the activity of the substances was directly related to the presence of a 6-substituent. Thus, 6-substituted derivatives of 3-azabicyclo[3.1.0]hexane did not possess antiproliferative activity and could be of interest only as potential antitussive and hypoglycemic drugs.
Similar content being viewed by others
References
W. Wang, Y. Mi, X.-P. Cao, and Z.-F. Shi, Org. Lett., 21(17), 6603 – 6607 (2019).
D. L. Boger, C. W. Boyce, R. M. Garbaccio, and J. A. Goldberg, Chem. Rev., 97(3), 787 – 828 (1997).
S. Gomi, D. Ikeda, H. Nakamura, H. Naganawa, et al., J. Antibiot. (Tokyo), 37(11), 1491 – 1494 (1984).
B. Witkop, Y. Fujimoto, F. Irreverre, et al., J. Am. Chem. Soc., 93(14), 3471 – 3477 (1971).
R. Ganorkar, A. Natarajan, A. Mamai, and J. S. Madalengoitia, J. Org. Chem., 71(13), 5004 – 5007 (2006).
K. Shimamoto, M. Ishida, H. Shinozaki, and Y. Ohfune, J. Org. Chem., 56(13), 4167 – 4176 (1991).
T. Morikawa, H. Sasaki, R. Hanai, et al., J. Org. Chem., 59(1), 97 – 103 (1994).
S. R McCabe and P. Wipf, Synthesis, 51(1), 213 – 224 (2019).
P. Chen, C. Zhu, R. Zhu, et al., Org. Biomol. Chem., 15, 1228 – 1235 (2017).
G. Lunn, B. J. Banks, R. Crook, et al., Bioorg. Med. Chem. Lett., 21(15), 4608 – 4611 (2011).
G. Lunn, L. R. Roberts, S. Content, et al., Bioorg. Med. Chem. Lett., 22(6), 2200 – 2203 (2012).
D. Moffat, S. Patel, F. Day, et al., J. Med. Chem., 53(24), 8663 – 8678 (2010).
J. A. Sattigeri, M. M. S. Andappan, K. Kishore, et al., Bioorg. Med. Chem. Lett., 18(14), 4087 – 4091 (2008).
A. Mamai, R. Zhang, A. Natarajan, and J. S. Madalengoitia, J. Org. Chem., 66(2), 455 – 460 (2001).
R. V. Golubev, A. Yu. Alekseeva, I. N. Bardasov, et al., Russ. J. Org. Chem., 47(3), 363 – 365 (2011).
I. N. Bardasov, D. L. Mikhailov, A. Yu. Alekseeva, et al., Russ. J. Org. Chem., 51(6), 849 – 852 (2015).
I. N. Bardasov, O. V. Kayukova, Ya. S. Kayukov, et al., Russ. J. Org. Chem., 45(9), 1325 – 1335 (2009).
D. L. Boger and D. S. Johnson, Angew. Chem., Int. Ed. Engl., 35(13 – 14), 1438 – 1474 (1996).
D. L. Boger, D. S. Johnson, and W. Wrasidlo, Bioorg. Med. Chem. Lett., 4(4), 631 – 636 (1994).
F. F. Fleming, L. Yao, P. C. Ravikumar, L. Funk, and B. C. Shook, J. Med. Chem., 53, 7902 – 7917 (2010).
A. Monks and D. Scudiero, J. Natl. Cancer Inst., 83(11), 757 – 766 (1991).
https: // dtp.cancer.gov / discovery development/nci-60/cell_list.htm.
GPM. 1.1.0014.15, State Pharmacopoeia of the Russian Federation, XIVth Ed., Vol. 1, (2018), pp. 319 – 369; http://femb.ru/femb/pharmacopea.php.
Acknowledgments
The work was performed in the framework of a State Task from the Ministry of Education and Science of Russia, Project No. 0849-2020-0003.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 54, No. 8, pp. 7 – 9, August, 2020.
Rights and permissions
About this article
Cite this article
Bardasov, I.N., Alekseeva, A.Y., Ershov, O.V. et al. Antiproliferative Activity Missing in 6-Substituted Polycarbonitrile Derivatives of 3-Azabicyclo[3.1.0]Hexane. Pharm Chem J 54, 781–783 (2020). https://doi.org/10.1007/s11094-020-02273-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-020-02273-0